136 related articles for article (PubMed ID: 35651273)
1. Restoration of c-Src/Fyn Proteins Rescues Mitochondrial Dysfunction in Huntington's Disease.
Fão L; Coelho P; Duarte L; Vilaça R; Hayden MR; Mota SI; Rego AC
Antioxid Redox Signal; 2023 Jan; 38(1-3):95-114. PubMed ID: 35651273
[No Abstract] [Full Text] [Related]
2. Restored Fyn Levels in Huntington's Disease Contributes to Enhanced Synaptic GluN2B-Composed NMDA Receptors and CREB Activity.
Fão L; Coelho P; Rodrigues RJ; Rego AC
Cells; 2022 Sep; 11(19):. PubMed ID: 36231023
[No Abstract] [Full Text] [Related]
3. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
[TBL] [Abstract][Full Text] [Related]
4. Targeting the proteostasis network in Huntington's disease.
Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA
Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease.
Fão L; Rego AC
Antioxid Redox Signal; 2021 Mar; 34(8):650-673. PubMed ID: 32498555
[No Abstract] [Full Text] [Related]
6. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ
Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516
[TBL] [Abstract][Full Text] [Related]
7. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
Aladdin A; Király R; Boto P; Regdon Z; Tar K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
[TBL] [Abstract][Full Text] [Related]
8. Mutant huntingtin fails to directly impair brain mitochondria.
Hamilton J; Brustovetsky T; Brustovetsky N
J Neurochem; 2019 Dec; 151(6):716-731. PubMed ID: 31418857
[TBL] [Abstract][Full Text] [Related]
9. Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington's Disease.
Ferreira IL; Carmo C; Naia L; I Mota S; Cristina Rego A
Methods Mol Biol; 2018; 1780():415-442. PubMed ID: 29856029
[TBL] [Abstract][Full Text] [Related]
10. Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.
Yablonska S; Ganesan V; Ferrando LM; Kim J; Pyzel A; Baranova OV; Khattar NK; Larkin TM; Baranov SV; Chen N; Strohlein CE; Stevens DA; Wang X; Chang YF; Schurdak ME; Carlisle DL; Minden JS; Friedlander RM
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16593-16602. PubMed ID: 31346086
[TBL] [Abstract][Full Text] [Related]
11. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
[TBL] [Abstract][Full Text] [Related]
12. Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.
Bryan MR; Bowman AB
Adv Neurobiol; 2017; 18():113-142. PubMed ID: 28889265
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
14. Meldonium improves Huntington's disease mitochondrial dysfunction by restoring peroxisome proliferator-activated receptor γ coactivator 1α expression.
Di Cristo F; Finicelli M; Digilio FA; Paladino S; Valentino A; Scialò F; D'Apolito M; Saturnino C; Galderisi U; Giordano A; Melone MAB; Peluso G
J Cell Physiol; 2019 Jun; 234(6):9233-9246. PubMed ID: 30362565
[TBL] [Abstract][Full Text] [Related]
15. PINK1-induced mitophagy promotes neuroprotection in Huntington's disease.
Khalil B; El Fissi N; Aouane A; Cabirol-Pol MJ; Rival T; Liévens JC
Cell Death Dis; 2015 Jan; 6(1):e1617. PubMed ID: 25611391
[TBL] [Abstract][Full Text] [Related]
16. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
Naia L; Ferreira IL; Cunha-Oliveira T; Duarte AI; Ribeiro M; Rosenstock TR; Laço MN; Ribeiro MJ; Oliveira CR; Saudou F; Humbert S; Rego AC
Mol Neurobiol; 2015 Feb; 51(1):331-48. PubMed ID: 24841383
[TBL] [Abstract][Full Text] [Related]
17. Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.
Naia L; Cunha-Oliveira T; Rodrigues J; Rosenstock TR; Oliveira A; Ribeiro M; Carmo C; Oliveira-Sousa SI; Duarte AI; Hayden MR; Rego AC
J Neurosci; 2017 Mar; 37(10):2776-2794. PubMed ID: 28123081
[TBL] [Abstract][Full Text] [Related]
18. Drp1 phosphorylation by MAPK1 causes mitochondrial dysfunction in cell culture model of Huntington's disease.
Roe AJ; Qi X
Biochem Biophys Res Commun; 2018 Feb; 496(2):706-711. PubMed ID: 29397067
[TBL] [Abstract][Full Text] [Related]
19. Morphological control of mitochondria as the novel mechanism of Gastrodia elata in attenuating mutant huntingtin-induced protein aggregations.
Huang NK; Lin CC; Lin YL; Huang CL; Chiou CT; Lee YC; Lee SY; Huang HT; Yang YC
Phytomedicine; 2019 Jun; 59():152756. PubMed ID: 31004885
[TBL] [Abstract][Full Text] [Related]
20. miR-302 Attenuates Mutant Huntingtin-Induced Cytotoxicity through Restoration of Autophagy and Insulin Sensitivity.
Chang CC; Tsou SH; Chen WJ; Ho YJ; Hung HC; Liu GY; Singh SK; Li HH; Lin CL
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
